Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of MK-0431D (Sitagliptin/Simvastatin) in T2DM Patients on Metformin
NCT01702298Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2012
- Primary completion
- May 2013
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of sitagliptin + simvastatin in type 2 diabetes mellitus (T2DM), sponsored by Merck & Co.. Started Dec 2012; status: completed.
02
Drugs
sitagliptin + simvastatin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01702298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01702298.